home / stock / ingn / ingn quote
Last: | $9.67 |
---|---|
Change Percent: | -2.27% |
Open: | $9.92 |
Close: | $9.67 |
High: | $9.92 |
Low: | $9.46 |
Volume: | 140,068 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$9.67 | $9.92 | $9.67 | $9.92 | $9.46 | 140,068 | 07-26-2024 |
$9.7 | $9.37 | $9.7 | $9.83 | $9.2 | 127,960 | 07-25-2024 |
$9.4 | $9.56 | $9.4 | $9.68 | $9.29 | 107,093 | 07-24-2024 |
$9.63 | $9.12 | $9.63 | $9.68 | $8.99 | 141,958 | 07-23-2024 |
$9.19 | $9.24 | $9.19 | $9.4 | $8.94 | 168,005 | 07-22-2024 |
$9.25 | $9.04 | $9.25 | $9.51 | $8.9 | 186,146 | 07-19-2024 |
$9.03 | $9.36 | $9.03 | $9.8 | $9 | 153,847 | 07-18-2024 |
$9.62 | $9.36 | $9.62 | $9.91 | $9.312 | 281,921 | 07-17-2024 |
$9.75 | $9.41 | $9.75 | $9.9 | $9.19 | 329,855 | 07-16-2024 |
$9.19 | $9.1 | $9.19 | $9.289 | $8.9 | 228,178 | 07-15-2024 |
$9.01 | $9.18 | $9.01 | $9.365 | $8.95 | 224,443 | 07-12-2024 |
$9 | $8.83 | $9 | $9.16 | $8.69 | 273,803 | 07-11-2024 |
$8.47 | $8.62 | $8.47 | $8.8 | $8.3 | 107,723 | 07-10-2024 |
$8.72 | $8.78 | $8.72 | $8.82 | $8.47 | 76,828 | 07-09-2024 |
$8.82 | $8.31 | $8.82 | $8.95 | $8.31 | 162,881 | 07-08-2024 |
$8.25 | $8.08 | $8.25 | $8.31 | $7.99 | 88,175 | 07-05-2024 |
$8.08 | $7.72 | $8.08 | $8.12 | $7.63 | 76,303 | 07-04-2024 |
$8.08 | $7.72 | $8.08 | $8.12 | $7.63 | 76,303 | 07-03-2024 |
$7.67 | $7.83 | $7.67 | $7.83 | $7.62 | 90,135 | 07-02-2024 |
$7.83 | $8.15 | $7.83 | $8.295 | $7.82 | 112,672 | 07-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter 2024 financial results after the market closes on Tuesday, August 6, 2024. On the same day, the Company wil...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith jo...